Prostate Cancer - Results from #60

Estimating copy number to determine BRCA2 deletion status and to expect prognosis in localized prostate cancer. January 18, 2023

Outcomes following brachytherapy boost for intermediate- and high-risk prostate cancer: a retrospective bicenter study by the SFRO Brachytherapy Group. January 18, 2023

Developing a novel patient reported outcomes measure for prostate cancer patients receiving radionuclide therapy. January 18, 2023

Validation of a surface-based deformable MRI-3D ultrasound image registration algorithm toward clinical implementation for interstitial prostate brachytherapy. January 17, 2023

Defining Patient Benefits from High-intensity Intermittent Therapy for Hormone-sensitive Prostate Cancer. January 17, 2023

Applications of artificial intelligence in prostate cancer histopathology. January 17, 2023

PSMA-PET/CT guided intensification of radiotherapy for prostate cancer (PSMAgRT): Findings of detection rate, impact on cancer management, and early toxicity from a phase 2 randomised controlled trial. January 17, 2023

A low prostate specific antigen predicts a worse outcome in high but not in low/intermediate-grade prostate cancer. January 17, 2023

Magnetic Resonance Imaging-Guided vs Computed Tomography-Guided Stereotactic Body Radiotherapy for Prostate Cancer: The MIRAGE Randomized Clinical Trial. January 17, 2023

Revisiting current National Comprehensive Cancer Network (NCCN) high-risk prostate cancer stratification: a National Cancer Database analysis. January 16, 2023

Association of Brachytherapy Boost with Overall Survival for Gleason 9-10 Prostate Cancer: The Impact of Primary versus Secondary Pattern 5. January 16, 2023

Validating the total cancer location density metric for stratifying patients with low-risk localized prostate cancer at higher risk of grade group reclassification while on active surveillance. January 16, 2023

Prostate cancer lesion detection, volume quantification and high-grade cancer differentiation using cancer risk maps derived from multiparametric MRI with histopathology as the reference standard. January 16, 2023

Mapping European Association of Urology Guideline Practice Across Europe: An Audit of Androgen Deprivation Therapy Use Before Prostate Cancer Surgery in 6598 Cases in 187 Hospitals Across 31 European Countries. January 16, 2023

Impact of Prostate Urethral Lift Device on Prostate MR Image Quality. January 13, 2023

Clinical implications of endogenous testosterone density on prostate cancer progression in patients with very favorable low and intermediate risk treated with radical prostatectomy. January 13, 2023

Prostate cancer disparities among American Indians/Alaskan Natives in the United States. January 13, 2023

Evaluation of Social Determinants of Health and Prostate Cancer Outcomes Among Black and White Patients: A Systematic Review and Meta-analysis. January 13, 2023

Advances in preclinical models of prostate cancer for research discovery. January 13, 2023

Prostate Cancer Foundation Health Equities Expert Panel To Establish Screening Guidelines For Black Men January 12, 2023

Page 4 of 1276

email news signup